We aspire to unite by creating continuous synergies across the team and partnerships.
Pharmaceuticals R&D and registration centre IRWIN 2 is a modern laboratory inside IRWIN 2 LLC that is engaged in designing the drugs of import replacement programme thereby growing domestic production of socially critical preparations and making quality and safe medicines available to wider audience.
Produces, stores and sells non-sterile solid dosage forms: tablets, film-coated tablets, capsules, powders and granules in sachets; packages its own preparations as well as renders production and packaging services on contractual basis.
The enterprise operates as a retail packaging agent of bulk product supplied either fully unpacked or in primary packaging, and in the following dosage forms:
In 2022, PharmEco Group began the implementation of its project focused on setting up, in Technopolis Moscow, an import replacement production of biotech drugs called BIOJET.
Bioject will be engaged in design and production of biotechnological medications based on monoclonal antibodies in full cycle right from the manufacture of the active pharmaceutical substance.
The projected capacity of the enterprise is up to 120 kg of active biopharmaceutical substances and 5M vials of ready-to-use product a year.
Production is expected to be launched in Q4 of 2023.
A pharmaceutical distributor supplying medicines, medicinal products and equipment across Russia.
The company specialises in providing logistics and warehousing services to pharmaceutical companies. The warehouse complies with all international and Russian standards of drug storage, including special temperature regimes and a “cold chain”.